Optimizing AAV2/6 microglial targeting identified enhanced efficiency in the photoreceptor degenerative environment
Open accessThe DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.
Abstract
Abstract Adeno-associated viruses (AAVs) are widely used to deliver genetic material in vivo to distinct cell types such as neurons or glial cells allowing for targeted manipulation. Transduction of microglia is mostly excluded from this strategy likely due to the cells’ heterogeneous state upon environmental changes, which makes AAV design challenging. Here, we established the retina as a model system for microglial AAV validation and optimization. First, we show that AAV2/6 transduced microglia in both synaptic layers, where layer preference corresponds to the intravitreal or subretinal delivery method. Surprisingly, we observed significantly enhanced microglial transduction during photoreceptor degeneration. Thus, we modified the AAV6 capsid to reduce heparin binding resulting in increased microglial transduction in the outer plexiform layer. Finally, to improve microglial-specific transduction, we validated a Cre-dependent transgene delivery cassette.Together, our results provide a foundation for future studies optimizing AAV-mediated microglia transduction and highlight that environmental conditions influence microglial transduction efficiency.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Zhang, Y., Chen, K., Sloan, S. A., Bennett, M. L., Scholze, A. R., O'Keeffe, S., Phatnani, H. P., Guarnieri, P., Caneda, C., Ruderisch, N., et al. (2014) · The Journal of Neuroscience · doi:10.1523/jneurosci.1860-14.2014 · Cited by 4,875
Identification of a unique TGF-β–dependent molecular and functional signature in microglia
Butovsky, O., Jedrychowski, M. P., Moore, C. S., Cialic, R., Lanser, A. J., Gabriely, G., Koeglsperger, T., Dake, B., Wu, P. M., Doykan, C. E., et al. (2014) · Nature Neuroscience · doi:10.1038/nn.3599 · Cited by 2,543
Chan, K. Y., Jang, M. J., Yoo, B. B., Greenbaum, A., Ravi, N., Wu, W.-L., Sánchez-Guardado, L., Lois, C., Mazmanian, S. K., Deverman, B. E., et al. (2017) · Nature Neuroscience · doi:10.1038/nn.4593 · Cited by 1,578
The P2Y12 receptor regulates microglial activation by extracellular nucleotides
Haynes, S. E., Hollopeter, G., Yang, G., Kurpius, D., Dailey, M. E., Gan, W.-B., & Julius, D. (2006) · Nature Neuroscience · doi:10.1038/nn1805 · Cited by 1,542 · cited 1×
“, for activity alteration [purinergic receptor P2Y12] or depletion [colony-stimulating factor 1 receptor] strategies).(10,11) Therefore, AAVs could provide a comparatively quick alternative to deliver the desired cargo necessary to investigate new research questions.”
BackgroundMicroglia and brain macrophages in the molecular age: from origin to neuropsychiatric disease
Prinz, M., & Priller, J. (2014) · Nature Reviews Neuroscience · doi:10.1038/nrn3722 · Cited by 1,329 · cited 1×
“After 2 weeks, we performed immunostaining for eGFP and ionized calcium-binding adaptor molecule 1 (Iba1) to label the microglial population.(27) To assess microglial transduction efficiency, we calculated the ratio of”
MethodAn environment-dependent transcriptional network specifies human microglia identity
Gosselin, D., Skola, D., Coufal, N. G., Holtman, I. R., Schlachetzki, J. C. M., Sajti, E., Jaeger, B. N., O’Connor, C., Fitzpatrick, C., Pasillas, M. P., et al. (2017) · Science · doi:10.1126/science.aal3222 · Cited by 1,220
Microglia development follows a stepwise program to regulate brain homeostasis
Matcovitch-Natan, O., Winter, D. R., Giladi, A., Vargas Aguilar, S., Spinrad, A., Sarrazin, S., Ben-Yehuda, H., David, E., Zelada González, F., Perrin, P., et al. (2016) · Science · doi:10.1126/science.aad8670 · Cited by 1,180 · cited 1×
“This mouse model is advantageous over the constitutive Cx3cr1-Cre, since expression of this receptor is only microglia/macrophage specific after embryonic day 18.(44)We subretinally injected the scAAV2/6-CD68-”
BackgroundEngineering adeno-associated virus vectors for gene therapy
Li, C., & Samulski, R. J. (2020) · Nature Reviews Genetics · doi:10.1038/s41576-019-0205-4 · Cited by 1,175
Negative feedback control of neuronal activity by microglia
Badimon, A., Strasburger, H. J., Ayata, P., Chen, X., Nair, A., Ikegami, A., Hwang, P., Chan, A. T., Graves, S. M., Uweru, J. O., et al. (2020) · Nature · doi:10.1038/s41586-020-2777-8 · Cited by 979 · cited 1×
“Yet, we need strategies to selectively alter microglia to obtain knowledge about their function within local environments and to identify their impact in disease onset and progression.(6,7) Currently, the field is limited to generating gene-of-interest knockoutmousemodels(8,9) or to a small number of microglia recepto…”
MethodRetinal degeneration mutants in the mouse
Chang, B., Hawes, N. L., Hurd, R. E., Davisson, M. T., Nusinowitz, S., & Heckenlively, J. R. (2002) · Vision Research · doi:10.1016/s0042-6989(01)00146-8 · Cited by 840
Microglia Heterogeneity in the Single-Cell Era
Masuda, T., Sankowski, R., Staszewski, O., & Prinz, M. (2020) · Cell Reports · doi:10.1016/j.celrep.2020.01.010 · Cited by 784
Dalkara, D., Byrne, L. C., Klimczak, R. R., Visel, M., Yin, L., Merigan, W. H., Flannery, J. G., & Schaffer, D. V. (2013) · Science Translational Medicine · doi:10.1126/scitranslmed.3005708 · Cited by 734
Self-complementary AAV vectors; advances and applications
McCarty, D. M. (2008) · Molecular Therapy · doi:10.1038/mt.2008.171 · Cited by 515
Microglia activation in retinal degeneration
Langmann, T. (2007) · Journal of Leukocyte Biology · doi:10.1189/jlb.0207114 · Cited by 496
O’Koren, E. G., Yu, C., Klingeborn, M., Wong, A. Y. W., Prigge, C. L., Mathew, R., Kalnitsky, J., Msallam, R. A., Silvin, A., Kay, J. N., et al. (2019) · Immunity · doi:10.1016/j.immuni.2019.02.007 · Cited by 440
Inner limiting membrane barriers to aav-mediated retinal transduction from the vitreous
Dalkara, D., Kolstad, K. D., Caporale, N., Visel, M., Klimczak, R. R., Schaffer, D. V., & Flannery, J. G. (2009) · Molecular Therapy · doi:10.1038/mt.2009.181 · Cited by 357
AAV cis -regulatory sequences are correlated with ocular toxicity
Xiong, W., Wu, D. M., Xue, Y., Wang, S. K., Chung, M. J., Ji, X., Rana, P., Zhao, S. R., Mai, S., & Cepko, C. L. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1821000116 · Cited by 249
Embryonic and postnatal development of microglial cells in the mouse retina
Santos, A. M., Calvente, R., Tassi, M., Carrasco, M., Martín‐Oliva, D., Marín‐Teva, J. L., Navascués, J., & Cuadros, M. A. (2008) · Journal of Comparative Neurology · doi:10.1002/cne.21538 · Cited by 213 · cited 1×
“The retina provides an ideal model, as its highly ordered structure demarcates two synaptic layers, eachoccupied by distinct microglial niches.(21,22) Viral delivery is fast and minimally invasive, and several well-characterized degenerative disease models are available, along with known disease-associated microglial…”
BackgroundNectow, A. R., & Nestler, E. J. (2020) · Nature reviews. Neuroscience · doi:10.1038/s41583-020-00382-z · Cited by 159 · cited 1×
“By combining known cellular tropism of AAV capsid serotypes with cell-type-selective promoters, this goal has beenmet formany neurons and glia.(12,13) For microglia, neither in vitro screens of several capsids with a constitutive promoter(14,15) nor an in vivo screen of three capsids andover 200 synthetic promoters(14…”
BackgroundScholz, R., Caramoy, A., Bhuckory, M. B., Rashid, K., Chen, M., Xu, H., Grimm, C., & Langmann, T. (2015) · Journal of Neuroinflammation · doi:10.1186/s12974-015-0422-5 · Cited by 111
Targeting Microglia Using Cx3cr1-Cre Lines: Revisiting the Specificity
Zhao, X.-F., Alam, M. M., Liao, Y., Huang, T., Mathur, R., Zhu, X., & Huang, Y. (2019) · eneuro · doi:10.1523/eneuro.0114-19.2019 · Cited by 92
Ronning, K. E., Karlen, S. J., Miller, E. B., & Burns, M. E. (2019) · Scientific Reports · doi:10.1038/s41598-019-41141-0 · Cited by 88
Åkerblom, M., Sachdeva, R., Quintino, L., Wettergren, E. E., Chapman, K. Z., Manfre, G., Lindvall, O., Lundberg, C., & Jakobsson, J. (2013) · Nature Communications · doi:10.1038/ncomms2801 · Cited by 85
Boye, S. L., Bennett, A., Scalabrino, M. L., McCullough, K. T., Van Vliet, K., Choudhury, S., Ruan, Q., Peterson, J., Agbandje-McKenna, M., & Boye, S. E. (2016) · Journal of Virology · doi:10.1128/jvi.00200-16 · Cited by 79
Adenoassociated virus serotype 9-mediated gene therapy for x-linked adrenoleukodystrophy
Gong, Y., Mu, D., Prabhakar, S., Moser, A., Musolino, P., Ren, J., Breakefield, X. O., Maguire, C. A., & Eichler, F. S. (2015) · Molecular Therapy · doi:10.1038/mt.2015.6 · Cited by 74
Fischer, K. B., Collins, H. K., & Callaway, E. M. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1915974116 · Cited by 69 · cited 2×
“This could be attributed to spontaneous transgene inversion during AAV production.(49) Indeed, we observed similar off-target expression in the ONL of both Cx3cr1 mice without tamoxifen and C57BL6/J with tamoxifen (Figure 5D).”
BackgroundThe future of retinal gene therapy: evolving from subretinal to intravitreal vector delivery
Ross, M., & Ofri, R. (2021) · Neural Regeneration Research · doi:10.4103/1673-5374.306063 · Cited by 67
Woodard, K. T., Liang, K. J., Bennett, W. C., & Samulski, R. J. (2016) · Journal of Virology · doi:10.1128/jvi.01568-16 · Cited by 59 · cited 1×
“AAV2 capsid has a high affinity for heparin and accumulates at the inner limiting membrane, which requires HSPG binding to pass through.(38,54) In contrast, AAV6 uses both HSPG and sialic acid for cellular attachment and entry and displays a weaker heparin-binding affinity than AAV2 capsid.”
BackgroundCao, X., Yung, J., Mak, H., & Leung, C. K. S. (2019) · Gene Therapy · doi:10.1038/s41434-019-0060-0 · Cited by 20
Cited by
Directed evolution of adeno-associated virus for efficient gene delivery to microglia
Lin, R., Zhou, Y., Yan, T., Wang, R., Li, H., Wu, Z., Zhang, X., Zhou, X., Zhao, F., Zhang, L., et al. (2022) · Nature Methods · doi:10.1038/s41592-022-01547-7 · Cited by 171
“Despite their ability to transduce a wide range of cell types in mammals, rAAVs packaged using existing AAV capsids have not achieved a high transduction rate and a sufficient transgene expression level in microglia, especially in vivo 25–30 .”
Zhou, L., Wang, Y., Xu, Y., Zhang, Y., & Zhu, C. (2024) · Journal of Neuroinflammation · doi:10.1186/s12974-024-03232-2 · Cited by 26
“Further efforts with rAAV6TM-GFP utilizing a CD68 promoter for subretinal and intravitreal targeting of retinal microglia yielded a mere 1.5% GFP + cells, with less than 10% of these being microglia, underscoring the challenges in achieving efficient and specific microglial targeting [47].”
BackgroundInfluentialRen, T., Zhu, M., Jiang, X., Xu, L., Jin, H., Zhou, Y., Zhao, Y., Zhuo, R., Li, W., Chen, C., et al. (2025) · Cell Reports · doi:10.1016/j.celrep.2025.115875 · Cited by 16
AAV vectors for specific and efficient gene expression in microglia
Aoki, R., Konno, A., Hosoi, N., Kawabata, H., & Hirai, H. (2025) · Cell Reports Methods · doi:10.1016/j.crmeth.2025.101116 · Cited by 12
Microglia targeting by adeno-associated viral vectors
Stamataki, M., Rissiek, B., Magnus, T., & Körbelin, J. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1425892 · Cited by 12
Metadata
- Authors
- Maes, M. E., Wögenstein, G. M., Colombo, G., Casado-Polanco, R., & Siegert, S.
- Venue
- Molecular Therapy - Methods & Clinical Development
- Publisher
- Elsevier BV
- Published
- 2021-12
- Volume
- 23
- Pages
- 210-224
- ISSN
- 2329-0501 (ISSN-L)
- OpenAlex
- W3201404324
- Cited by
- 12
- References
- 29
- FWCI
- 1.01
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.